Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

July 15, 2019August 20, 2019

Prenatal Blood Test for SMA and Other Single-Gene Diseases Now Available, BillionToOne Announces

News

The diagnostics company BillionToOne has launched its first product for commercial and clinical use — a blood test designed to help diagnose hereditary and rare diseases in fetuses. Called UNITY, the ... Read more

July 10, 2019July 10, 2019

Adding Reldesemtiv to Spinraza or Investigational SMN-C1 Improved Muscle Function in SMA Mouse Model

News

Adding reldesemtiv to survival of motor neuron (SMN) restoration therapies — namely Spinraza (nusinersen) or the investigational SMN-C1 (an analogue to risdiplam) — can improve muscle function in a ... Read more

January 11, 2019February 4, 2019

Many Parents Believe Healthcare for Children with SMA Needs Improvement, Study Reports

News

Optimal care of children with spinal muscular atrophy (SMA) requires improving competence and an adequate exchange of knowledge among healthcare professionals, as well maintaining a close dialogue with the ... Read more

December 21, 2018January 4, 2019

Risdiplam Granted EMA’s PRIME Designation for Potential in Spinal Muscular Atrophy

News

The European Medicines Agency has granted a priority medicines, or PRIME, designation to oral therapy candidate risdiplam to treat spinal muscular atrophy (SMA). PRIME designation is intended to encourage the development of ... Read more

November 14, 2018November 20, 2018

New Technique, MUNIX, May Capture Motor Neuron Loss and Muscle Status in Type 3 and 4 Adults

News

A non-invasive electrophysiology technique called motor unit number index, or MUNIX, can effectively assess the loss of motor nerve cells and muscle impairment in adults with spinal muscular atrophy ... Read more

August 6, 2018August 8, 2018

Mizzou Researchers Launch Shift Pharmaceuticals to Test Potential SMA Therapy

News

Researchers at Mizzou — the University of Missouri — have started a new company, Shift Pharmaceuticals, to test the clinical effectiveness of a molecule that may help improve the ... Read more

July 20, 2018July 24, 2018

Early Spinraza Treatment Improves Outcomes of Children with SMA, Study Shows

News

Young children with spinal muscular atrophy show improvements in motor function after six-months of treatment with Spinraza, a German study shows. The response to Spinraza strongly correlated with the age ... Read more

April 2, 2018April 3, 2018

ALS Research Could Shed Light on What Drives SMA, Study Reports

News

According to scientists, new research on ALS may shed light on the mechanisms underlying spinal muscular atrophy. Two RNA binding proteins, TDP-43 and hnRNP A1, are abnormal in certain cases ... Read more

February 7, 2018February 7, 2018

Genetic Network Identified Regulating Motor Neuron Formation in Embryo’s Development

News

Researchers have uncovered the gene network regulating the transition of progenitor cells into motor neurons during the development of embryos, using chicken and mice as models. The study also ... Read more

February 5, 2018February 5, 2018

Scholar Rock Therapy Prevents Additional Atrophy in Mice with Muscle Wasting, Study Shows

News

Scholar Rock’s SRK-015 prevented additional atrophy in mice with muscle wasting and increased healthy animals’ muscle mass and function, a study reports. The biotech company’s therapy targets the precursor to the ... Read more

Pin It on Pinterest